Duchenne muscular dystrophy (DMD), a highly fatal hereditary disorder, affects one in every 3,600 young boys. It commonly begins with muscle weakness and loss in muscle mass. This muscle wasting is eventually replaced by fat and fibrotic tissue, eventually making it difficult to stand and walk, oftentimes by…
News
The MD-CARE Act, a piece of legislation designed to accelerate research and provide infrastructure needed for the development of new treatments to treat all nine forms of muscular dystrophy, has passed in the Senate by unanimous consent on September 18th. The Muscular Dystrophy Association (MDA), which has been a major advocate for passage of…
Recent Posts
- Sarepta won’t reopen enrollment in Duchenne gene therapy trial
- MDA Engage: California event highlights community connection
- New AI-based tool may predict when Duchenne kids will lose ability to walk
- Parent Project Muscular Dystrophy offers me chance to give back
- National Family Caregivers Month is a good opportunity to give thanks